Alabama High Court Okays Suit Against Pfizer for Failure to Warn of Generic's Risks

, The Litigation Daily

   | 0 Comments

The Alabama Supreme Court on Friday allowed a patient who claims that he was harmed by taking the generic version of a Pfizer drug to continue his suit against Pfizer. The ruling stands in contrast to a U.S. Supreme Court decision that bars users of generic drugs from bringing failure-to warn suits against the manufacturers of the brand-name counterparts.

This article has been archived, and is no longer available on this website.

View this content exclusively through LexisNexis® Here

Not a LexisNexis® Subscriber?

Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via lexis.com® and Nexis®. This includes content from The National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202584462657

Thank you!

This article's comments will be reviewed.